Remdesivir: Chemistry in its element
Apr 03, 2020•6 min
Episode description
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
For the best experience, listen in Metacast app for iOS or Android
